Romain Daillère

2013–2025 年に発表

28
論文数
18,409
被引用数
25
h 指数
28
i10 指数

被引用数

Romain Daillère の年別被引用数2005 年: 被引用 2 件2007 年: 被引用 1 件2013 年: 被引用 6 件2014 年: 被引用 28 件2015 年: 被引用 55 件2016 年: 被引用 139 件2017 年: 被引用 208 件2018 年: 被引用 441 件2019 年: 被引用 996 件2020 年: 被引用 1,404 件2021 年: 被引用 1,421 件2022 年: 被引用 1,396 件2023 年: 被引用 1,232 件2024 年: 被引用 1,474 件2025 年: 被引用 1,069 件2026 年: 被引用 67 件2006 年は被引用が無いため表示していません2008〜2012 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 2,158 件、この内訳の 23.2%アメリカ合衆国: 引用元論文 1,966 件、この内訳の 21.1%イタリア: 引用元論文 467 件、この内訳の 5%フランス: 引用元論文 460 件、この内訳の 4.9%イギリス: 引用元論文 357 件、この内訳の 3.8%ドイツ: 引用元論文 327 件、この内訳の 3.5%カナダ: 引用元論文 315 件、この内訳の 3.4%日本: 引用元論文 223 件、この内訳の 2.4%スペイン: 引用元論文 218 件、この内訳の 2.4%オーストラリア: 引用元論文 214 件、この内訳の 2.3%インド: 引用元論文 173 件、この内訳の 1.9%オランダ: 引用元論文 169 件、この内訳の 1.8%
0%23.2%その他 24.3%

分野

  • Biochemistry, Genetics and Molecular Biology44.9%
  • Medicine40.4%
  • Immunology and Microbiology8.5%
  • Agricultural and Biological Sciences1.6%
  • Engineering1.2%
  • Environmental Science0.9%
  • その他2.5%

トピック

  • Gut microbiota and health15.6%
  • Cancer Immunotherapy and Biomarkers11.2%
  • Clostridium difficile and Clostridium perfringens research4.3%
  • Immunotherapy and Immune Responses3.6%
  • Immune Cell Function and Interaction3.3%
  • Immune cells in cancer2.7%
  • その他59.3%

共著者

全論文

検索で開く
  1. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Benoît Quinquis, Nicolas Pons, Bernhard Ryffel, Véronique Minard-Colin, Patrick Gonin, Jean‐Charles Soria, Éric Deutsch, Yohann Loriot, François Ghiringhelli, Gérard Zalcman, François Goldwasser, Bernard Escudier, Matthew D. Hellmann, Alexander Eggermont, Didier Raoult, Laurence Albigès, Guido Kroemer, Laurence Zitvogel - Science 2017 被引用: 5,594

  2. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Caroline Robert, Christina Mateus, Guido Kroemer, Didier Raoult, Ivo G. Boneca, Franck Carbonnel, Mathias Chamaillard, Laurence Zitvogel - Science 2015 被引用: 3,456

  3. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hugo Roume, Agathe Dubuisson, Nicole Bouchard, Meriem Messaoudene, Damien Drubay, Éric Deutsch, Fabrice Barlési, David Planchard, Nicola Segata, Stéphanie Martinez, Laurence Zitvogel, Jean‐Charles Soria, Benjamin Besse - Nature Medicine 2022 被引用: 642

  4. The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ivo G. Boneca, François Ghiringhelli, Laurence Zitvogel - Science 2013 被引用: 2,027

  5. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip Rosenstiel, Didier Raoult, Vincent Cattoir, Ivo G. Boneca, Mathias Chamaillard, Laurence Zitvogel - Immunity 2016 被引用: 854

  6. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela Schippers, Norbert Wagner, Javier Suárez-Gosálvez, Sebastian Kobold, Jean‐Eudes Fahrner, Corentin Richard, Jacques Bosq, Leonardo Lordello, Giacomo Vitali, Nathalie Galleron, Benoît Quinquis, Emmanuelle Le Chatelier, Lucas Blanchard, Jean‐Philippe Girard, Anne Jarry, Nadine Gervois, Emmanuelle Godefroy, Nathalie Labarrière, Ronald Koschny, Romain Daillère, Benjamin Besse, Caroline Truntzer, François Ghiringhelli, Nicolas Coatnoan, Vanessa Mhanna, David Klatzmann, Damien Drubay, Laurence Albigès, Andrew Maltez Thomas, Nicola Segata, François‐Xavier Danlos, Aurélien Marabelle, Bertrand Routy, Lisa Derosa, Guido Kroemer, Laurence Zitvogel - Science 2023 被引用: 221

  7. Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edoardo Pasolli, Nicola Segata, Carlos López-Otı́n, Zoltán Szállási, Fabrice André, Valerio Iebba, Valentin Quiniou, David Klatzmann, Jacques Bou Khalil, S. Khelaifia, Didier Raoult, Laurence Albigès, Bernard Escudier, Alexander Eggermont, Fathia Mami‐Chouaib, Paola Nisticò, François Ghiringhelli, Bertrand Routy, Nathalie Labarrière, Vincent Cattoir, Guido Kroemer, Laurence Zitvogel - Science 2020 被引用: 384

  8. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernard Escudier, Guido Kroemer, Laurence Albigès, Laurence Zitvogel - European Urology 2020 被引用: 377

  9. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

    著者: , , , , , , , , , , - Immunity 2016 被引用: 1,053

  10. Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JCI Insight 2020 被引用: 512

  11. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Éric Deutsch, Karla A. Lee, Laura A. Bolte, Johannes R. Björk, Rinse K. Weersma, Fabrice Barlési, Lucas Padilha, Ana Finzel, Morten L. Isaksen, Bernard Escudier, Laurence Albigès, David Planchard, Fabrice André, Chiara Cremolini, Stéphanie Martinez, Benjamin Besse, Liping Zhao, Nicola Segata, Jérôme Wojcik, Guido Kroemer, Laurence Zitvogel - Cell 2024 被引用: 181

  12. The gut microbiota influences anticancer immunosurveillance and general health

    著者: , , , , , - Nature Reviews Clinical Oncology 2018 被引用: 504

  13. Anticancer effects of the microbiome and its products

    著者: , , , , - Nature Reviews Microbiology 2017 被引用: 526

  14. Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?

    著者: , , , , , , - Cancer Discovery 2021 被引用: 163

  15. Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites

    著者: , , , , , , , , , , , - Aging 2021 被引用: 155

  16. Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincenzo Bronte, Jennifer A. Wargo, Laurence Zitvogel - Cell Research 2019 被引用: 248

  17. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Yves Scoazec, Peggy Dartigues, Antoine Hollebecque, David Malka, Franck Pagès, Jérôme Galon, Ivo G. Boneca, Patricia Lepage, Bernard Ryffel, Didier Raoult, Alexander Eggermont, Tom Vanden Berghe, François Ghiringhelli, Peter Vandenabeele, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2020 被引用: 196

  18. Escherichia coli –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , François‐Xavier Danlos, Garett Dunsmore, Kevin Mulder, Aymeric Silvin, Thibault Raoult, Baptiste Archambaud, Shaima Belhechmi, Ivo G. Boneca, Nadège Cayet, Maryse Moya‐Nilges, Adeline Mallet, Romain Daillère, Étienne Rouleau, C. Radulescu, Yves Allory, Jacques Fieschi, Mathieu Rouanne, Florent Ginhoux, Gwénaël Le Teuff, Lisa Derosa, Aurélien Marabelle, Jeroen van Dorp, Nick van Dijk, Michiel S. van der Heijden, Benjamin Besse, Fabrice André, Miriam Mérad, Guido Kroemer, Jean‐Yves Scoazec, Laurence Zitvogel, Yohann Loriot - Cancer Discovery 2022 被引用: 76

  19. Cancer and the gut microbiota: An unexpected link

    著者: , , , , , , - Science Translational Medicine 2015 被引用: 461

  20. Mouse models in oncoimmunology

    著者: , , , , - Nature reviews. Cancer 2016 被引用: 347

  21. Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Florent Ginhoux, Antoine Toubert, Nicola Segata, Douglas G. McNeel, Karim Fizazi, Guido Kroemer, Laurence Zitvogel - Journal for ImmunoTherapy of Cancer 2022 被引用: 78

  22. Gut microbiome and anticancer immune response: really hot Sh*t!

    著者: , , , , , , , , , , - Cell Death and Differentiation 2014 被引用: 124

  23. Multifaceted modes of action of the anticancer probiotic Enterococcus hirae

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Death and Differentiation 2021 被引用: 51

  24. The impact of the intestinal microbiota in therapeutic responses against cancer

    著者: , , , , , - Comptes Rendus Biologies 2018 被引用: 92